Investments
79Portfolio Exits
29Funds
1About Advent Venture Partners
Founded in 1981, Advent Venture Partners is a venture capital firm in Europe. Advent has over Euro 500m of fund commitments under management, their focus is on venture and growth investment in two sectors: Life Sciences and Technology.
Advent Venture Partners Headquarter Location
158-160 North Gower Street
London, England, NW1 2ND,
United Kingdom
+44 (0)20 7932 2100
Latest Advent Venture Partners News
Jun 20, 2019
This included a $100m Series D equity financing and a $70m credit facility. The Series D equity financing included new investors 8VC, Opaleye Management, Pura Vida Investments, and existing investors OrbiMed, Deerfield Management Company, Advent Venture Partners, Xeraya Capital and GE Ventures. The credit facility was provided by OrbiMed Credit and Royalties Fund and Deerfield Management. The company intends to use the funds to accelerate commercialization and facilitate global business development activities. Proceeds will allow Acutus to increase market availability of its FDA and CE marked AcQMap™ products as well as a suite of FDA-cleared, EP-designed vascular access products – AcQCross QX, AcQGuide Flex™ and AcQGuide Mini™. Founded in 2011 by Vince Burgess, CEO, Acutus provides next-generation electrophysiology technology solutions that can enable personalized and adaptive approaches to therapy. Its AcQMap is cardiac imaging and mapping system that incorporates precision ultrasound atrial anatomy reconstruction and reproducible, high-definition non-contact charge density mapping. The system also provides workhorse contact mapping capabilities, available in Europe. AcQMap’s increased clarity of arrhythmia pattern mapping aids in the development of patient specific ablation strategies. FinSMEs 20/06/2019
Advent Venture Partners Investments
79 Investments
Advent Venture Partners has made 79 investments. Their latest investment was in Paxmedica as part of their Debt on November 11, 2020.
Advent Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
11/6/2020 | Debt | Paxmedica | $3M | Yes | 1 | |
6/20/2019 | Series D | Acutus Medical | $100M | Yes | 3 | |
5/4/2016 | Series F | Farfetch | $110M | No | 13 | |
3/3/2015 | Series D | |||||
12/31/2014 | Seed VC |
Date | 11/6/2020 | 6/20/2019 | 5/4/2016 | 3/3/2015 | 12/31/2014 |
---|---|---|---|---|---|
Round | Debt | Series D | Series F | Series D | Seed VC |
Company | Paxmedica | Acutus Medical | Farfetch | ||
Amount | $3M | $100M | $110M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 1 | 3 | 13 |
Advent Venture Partners Portfolio Exits
29 Portfolio Exits
Advent Venture Partners has 29 portfolio exits. Their latest portfolio exit was Acutus Medical on August 06, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
8/6/2020 | IPO | Public | 5 | ||
4/16/2019 | IPO | Public | 5 | ||
9/21/2018 | IPO | Public | 6 | ||
Date | 8/6/2020 | 4/16/2019 | 9/21/2018 | ||
---|---|---|---|---|---|
Exit | IPO | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | Public | ||
Sources | 5 | 5 | 6 |
Advent Venture Partners Acquisitions
3 Acquisitions
Advent Venture Partners acquired 3 companies. Their latest acquisition was Nexi on June 19, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
6/19/2015 | Acq - Fin | 2 | ||||
6/3/2009 | Debt | |||||
1/1/2002 |
Date | 6/19/2015 | 6/3/2009 | 1/1/2002 |
---|---|---|---|
Investment Stage | Debt | ||
Companies | |||
Valuation | |||
Total Funding | |||
Note | Acq - Fin | ||
Sources | 2 |
Advent Venture Partners Fund History
1 Fund History
Advent Venture Partners has 1 fund, including Advent Life Sciences Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/10/2014 | Advent Life Sciences Fund II | $146.3M | 1 |
Closing Date | 9/10/2014 |
---|---|
Fund | Advent Life Sciences Fund II |
Fund Type | |
Status | |
Amount | $146.3M |
Sources | 1 |
Advent Venture Partners Team
3 Team Members
Advent Venture Partners has 3 team members, including former General Partner, Peter Baines.
Name | Work History | Title | Status |
---|---|---|---|
Peter Baines | General Partner | Former | |
Michael Chalfen | Vault Platform, Mosaic Ventures, Apax Partners, and The Boston Consulting Group | General Partner | Former |
Frédéric Court | General Partner | Former |
Name | Peter Baines | Michael Chalfen | Frédéric Court |
---|---|---|---|
Work History | Vault Platform, Mosaic Ventures, Apax Partners, and The Boston Consulting Group | ||
Title | General Partner | General Partner | General Partner |
Status | Former | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.